NantHealth, Inc
NH was delisted on the 23rd of May, 2023.
42 hedge funds and large institutions have $4.8M invested in NantHealth, Inc in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 10 closing their positions.
54% more capital invested
Capital invested by funds: $3.12M → $4.8M (+$1.68M)
13% less funds holding
Funds holding: 48 → 42 (-6)
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$92.9K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$26.5K |
| 3 |
MMA
Miracle Mile Advisors
Los Angeles,
California
|
+$22.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.4K |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$7.72K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$87K |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$73.4K |
| 3 |
JP Morgan Chase
New York
|
-$57.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$45K |
| 5 |
BlackRock
New York
|
-$36.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| – | -$4K | -499 | Closed |
|
NH Hedge Fund Activity: Q1 2019 in Review
42 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q1 2019, worth a combined $4.8M — up 54% from $3.12M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of NH and 4 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 8 added.
The largest buyer was Renaissance Technologies, adding an estimated $92.9K. The largest seller was Goldman Sachs, exiting entirely with an estimated $87K sold.
- 42 institutional investors held NantHealth, Inc (NH) as of Q1 2019, down from 48 in Q4 2018.
- Funds reported $4.8M of NantHealth, Inc stock for Q1 2019, up 54% quarter-over-quarter.
- 4 funds opened new NantHealth, Inc positions in Q1 2019 and 10 closed out, a net change of -6 holders.
- The largest NantHealth, Inc buyer in Q1 2019 was Renaissance Technologies, an estimated $92.9K added.
- The largest NantHealth, Inc seller in Q1 2019 was Goldman Sachs, an estimated $87K sold.
Based on aggregated 13F filings for Q1 2019.